May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
October 24, 2022
University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.
April 13, 2023
The University of Cincinnati is enrolling patients in an Imvax study that will test the effectiveness of a personalized vaccine approach to fight deadly brain tumors.
April 14, 2023
University of Cincinnati Cancer Center researchers will present more than a dozen abstracts at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19, including findings that could advance treatments for head and neck and breast cancers.
October 17, 2023
The University of Cincinnati Cancer Center has joined the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN), providing patients with access to cutting edge treatments only available through the network.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
February 25, 2022
University of Cincinnati researchers led by Jiajie Diao and Yujie Sun have developed a new pH probe and imaging technique to provide researchers more information when studying diseases like cancer and Alzheimer's.
February 28, 2022
Researchers led by the University of Cincinnati's Dr. Trisha Wise-Draper led a clinical trial that showed immunotherapy drug pembrolizumab increased survival rates for head and neck cancer patients with intermediate risk.
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.